Gene therapy: GS030-DP AND Medical device: GS030-MD clinical trials

Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

This study is testing a new gene therapy called GS030 for people with Retinitis Pigmentosa (RP). It involves an injection into the eye and special glasses to see if it's safe and how well it's tolerated, aiming to improve vision.